An overview of the appropriability mechanisms used in plant biotechnology industry
DOI:
https://doi.org/10.31686/ijier.vol7.iss8.1687Keywords:
genetically modified organisms, innovation, blocking patents, barrier to entryAbstract
This paper aims to discuss the main appropriability mechanisms used by biotech firms to avoid imitation and appropriate the economic benefits from crop innovations. To this end, we analyze the strategic links between the technological development of genetically modified organisms (GMO) and the ownership rights over plant transformation technologies. We also discuss a key case study - the legal battle between Monsanto and Syngenta by the control of the GMO crops derived from the GA21 gene. Our findings show that a system of blocking patents has been built basically through strategies relating to intellectual property mechanisms. As result, Monsanto's efforts to sue competitors for patent infringement have proved to be a successful barrier to entry in plant biotechnology industry.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Vinícius Eduardo Ferrari, José Maria Jardim Ferreira da Silveira , Maria Ester Soares Dal-Poz
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
